Quantification of tumor microvascular permeability in human glioma xenografts using dynamic T1 MRI with Gadomer-17

Dynamic Magnetic Resonance Imaging (T1-mapping) using the Gadolinium complex Gadomer-17, was applied to characterize the vascular permeability of human glioma xenografts implanted in nude mice. We aimed at measuring permeability differences in two types of glioma xenograft lines with a known difference in perfusion status. The T1-data could be analyzed according to the Tofts-Kermode compartmental model for modeling tracer kinetics to vascular permeability. This vascular permeability was mapped as the permeability surface area product per unit of leakage volume (k). The two tumor types displayed different k-maps. For the fast growing E102 tumor, we observed a homogeneous distribution of the vascular permeability across the tumor with a mean k-value of (0.207 plus or minus 0.027) min-1. However, for the slowly growing E106 tumor, we could distinguish four different regions with different permeability characteristics: a well-perfused rim [k equals (0.30 plus or minus 0.09) min-1], regions at the inner side of the tumor with lower permeability [k equals (0.130 plus or minus 0.019) min-1], regions at the inner side of the tumor around necrotic regions demonstrating locally increased permeability [k equals (0.33 plus or minus 0.11) min-1], and necrotic regions.

[1]  E. Keshet,et al.  Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis , 1992, Nature.

[2]  B R Rosen,et al.  Dynamic Gd‐DTPA enhanced MRI measurement of tissue cell volume fraction , 1995, Magnetic resonance in medicine.

[3]  P. Tofts Modeling tracer kinetics in dynamic Gd‐DTPA MR imaging , 1997, Journal of magnetic resonance imaging : JMRI.

[4]  G. Adam,et al.  Dynamic contrast‐enhanced MR imaging of the upper abdomen: Enhancement properties of gadobutrol, gadolinium‐DTPA‐polylysine, and gadolinium‐DTPA‐cascade‐polymer , 1994, Magnetic resonance in medicine.

[5]  D M Shames,et al.  Comparison of albumin‐(Gd‐DTPA)30 and Gd‐DTPA‐24‐cascade‐polymer for measurements of normal and abnormal microvascular permeability , 1997, Journal of magnetic resonance imaging : JMRI.

[6]  H. Degani,et al.  High resolution MRI of MCF7 human breast tumors: Complemented use of iron oxide microspheres and Gd‐DTPA , 1998, Journal of magnetic resonance imaging : JMRI.

[7]  A R Padhani,et al.  Probing tumor microvascularity by measurement, analysis and display of contrast agent uptake kinetics , 1997, Journal of magnetic resonance imaging : JMRI.

[8]  H. Dvorak,et al.  Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. , 1983, Science.

[9]  D M Shames,et al.  Measurement of capillary permeability to macromolecules by dynamic magnetic resonance imaging: A quantitative noninvasive technique , 1993, Magnetic resonance in medicine.

[10]  B. Rosen,et al.  Perfusion imaging with NMR contrast agents , 1990, Magnetic resonance in medicine.

[11]  E. Manseau,et al.  Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. , 1993, Cancer research.

[12]  D M Shames,et al.  A MRI spatial mapping technique for microvascular permeability and tissue blood volume based on macromolecular contrast agent distribution , 1997, Magnetic resonance in medicine.

[13]  P S Tofts,et al.  Quantitative Analysis of Dynamic Gd‐DTPA Enhancement in Breast Tumors Using a Permeability Model , 1995, Magnetic resonance in medicine.